Zixiang Ye

Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine

Affiliated withPeking University China-Japan Friendship School of Clinical Medicine

Research Area

Biography

Zixiang Ye has not added Biography.
If you are Zixiang Ye and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2023

Other Publications

Article	Year
Governor vessel acupuncture for acute ischemic stroke: a systematic review and meta-analysis. Annals of palliative medicine\| PubMed ID: 34263625	2021
Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization. Frontiers in genetics\| PubMed ID: 34276770	2021
Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease. Frontiers in cardiovascular medicine\| PubMed ID: 35155621	2021
Prognostic nomograms for predicting overall survival and cancer-specific survival in patients with angiosarcoma, a SEER population-based study. Scientific reports\| PubMed ID: 35241714	2022
Predictive Value of the CHADS-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease. Frontiers in cardiovascular medicine\| PubMed ID: 35369355	2022
Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS). BMC cardiovascular disorders\| PubMed ID: 35597912	2022
Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention. International journal of cardiology\| PubMed ID: 35970443	2022
Long-Term Survival of FOLFIRINOX +toripalimab in a Patient with Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report. OncoTargets and therapy\| PubMed ID: 36046467	2022
Evaluating the predictive value of diabetes mellitus diagnosed according to the Chinese guidelines (2020 edition) for cardiovascular events. Diabetology & metabolic syndrome\| PubMed ID: 36163072	2022
The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults. BMC endocrine disorders\| PubMed ID: 36192720	2022
Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice. Frontiers in cardiovascular medicine\| PubMed ID: 36588571	2022
The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models. European journal of medical research\| PubMed ID: 36653875	2023
Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Cardiovascular diabetology\| PubMed ID: 37179310	2023
Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials. Frontiers in cardiovascular medicine\| PubMed ID: 37273883	2023